Şeyma Şumnu et al. took a retrospective study by comparing the expression of the S100A8/A9 level between 33 Hodgkin lymphoma (HL) patients and 20 healthy volunteers through ELISA and found it as a biomarker of inflammation in HL. Here, S100A8 is linked to Hodgkins lymphoma.